Literature DB >> 21562447

Ablation of pancreatic cystic lesions: the use of multiple endoscopic ultrasound-guided ethanol lavage sessions.

Christopher J DiMaio1, John M DeWitt, William R Brugge.   

Abstract

OBJECTIVES: Determine the effectiveness of multiple endoscopic ultrasound-guided ethanol lavage (EUS-EL) sessions for attempted ablation of pancreatic cystic lesion (PCL).
METHODS: Retrospective review of patients who have undergone 2 or more EUS-EL treatments of a PCL. Eligible patients had asymptomatic, benign-appearing PCL, no previous pancreatitis, and were considered poor surgical candidates.
RESULTS: Final analysis was performed on 13 patients with suspected branch duct intraductal papillary mucinous neoplasms. The mean maximum cyst diameter at baseline and after 1 and 2 EUS-EL treatments was 20.1 ± 7.1, 17.0 ± 9.8 (P = 0.06), and 12.8 ± 9.6 mm (P = 0.0002), respectively. The mean surface area after 2 EUS-EL sessions: baseline, 5734 ± 6846 mm(2); 1 EUS-EL session, 4906 ± 9240 mm(2) (P = 0.52); and 2 EUS-EL sessions, 2311 ± 4093 mm(2) (P = 0.008). Complete resolution of the cystic lesion was not seen by computed tomography or magnetic resonance imaging in any patient after 1 EUS-EL but occurred in 5 (38%; P = 0.02) of 13 patients after 2 EUS-EL treatments. One patient had minor abdominal pain 1 day after the first EUS-EL session and 2 days after the second session.
CONCLUSIONS: Compared with only 1 EUS-EL, 2 EUS-EL treatment results in a significantly greater decrease in the size and surface area of PCL and is associated with a significantly higher rate of image-defined cyst resolution.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562447     DOI: 10.1097/MPA.0b013e3182128d06

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  33 in total

Review 1.  Uncommon complications of therapeutic endoscopic ultrasonography: What, why, and how to prevent.

Authors:  Tanyaporn Chantarojanasiri; Pitulak Aswakul; Varayu Prachayakul
Journal:  World J Gastrointest Endosc       Date:  2015-08-10

2.  Success of endoscopic ultrasound-guided ethanol ablation of pancreatic cysts: a meta-analysis and systematic review.

Authors:  Manasa Kandula; Harsha Moole; Michael Cashman; Fritz H Volmar; Matthew L Bechtold; Srinivas R Puli
Journal:  Indian J Gastroenterol       Date:  2015-06-25

Review 3.  Benign Tumors and Tumorlike Lesions of the Pancreas.

Authors:  Olca Basturk; Gokce Askan
Journal:  Surg Pathol Clin       Date:  2016-12

Review 4.  Endoscopic Management of Pancreatic Cysts.

Authors:  Michael J Bartel; Massimo Raimondo
Journal:  Dig Dis Sci       Date:  2017-03-17       Impact factor: 3.199

Review 5.  Endoscopic ultrasound-guided ethanol ablation therapy for tumors.

Authors:  Wen-Ying Zhang; Zhao-Shen Li; Zhen-Dong Jin
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 6.  Endoscopic ultrasound-guided treatments: are we getting evidence based--a systematic review.

Authors:  Carlo Fabbri; Carmelo Luigiano; Andrea Lisotti; Vincenzo Cennamo; Clara Virgilio; Giancarlo Caletti; Pietro Fusaroli
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

Review 7.  Endosonography in the diagnosis and management of pancreatic cysts.

Authors:  Vivek Kadiyala; Linda S Lee
Journal:  World J Gastrointest Endosc       Date:  2015-03-16

8.  Interventional endoscopic ultrasonography.

Authors:  Lorenzo Fuccio; Fabia Attili; Giuseppe Vanella; Alberto Larghi
Journal:  Curr Treat Options Gastroenterol       Date:  2014-06

9.  Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumors.

Authors:  Madhava Pai; Nagy Habib; Hakan Senturk; Sundeep Lakhtakia; Nageshwar Reddy; Vito R Cicinnati; Iyad Kaba; Susanne Beckebaum; Panagiotis Drymousis; Michel Kahaleh; William Brugge
Journal:  World J Gastrointest Surg       Date:  2015-04-27

Review 10.  Cystic neoplasms of the pancreas.

Authors:  Anne Marie Lennon; Christopher Wolfgang
Journal:  J Gastrointest Surg       Date:  2013-01-24       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.